Celyad Company

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
Technology: CAR-T
Industry: CAR-T, Public
Headquarters: Mont-saint-guibert, Brabant Wallon, Belgium
Founded Date: 2007-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 5
Total Funding: 146096840
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-12-03
Last Funding Type: Post-IPO Equity

Visit Website
info@c3bs.com
https://twitter.com/CelyadSA
Register and Claim Ownership